tldrdailynews.com logo

FDA approves innovative drug for menopausal hot flashes.

1 min read
Source: GMA
FDA approves innovative drug for menopausal hot flashes.
Photo: GMA
TL;DR

The US FDA has approved a hormone-free drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause. The drug works by targeting the brain's temperature control center to decrease both the frequency and intensity of hot flashes in women. Prior to the FDA's approval of fezolinetant, the main treatment options for hot flashes related to menopause were hormone replacement therapy (HRT) and some types of antidepressants. Veozah is a once-a-day pill and is promising for women who cannot take hormone treatment because of other underlying health concerns.

Topics:businesshealth#fda-approval#fezolinetant#health#hormone-free#hot-flashes#menopause
Share this article
  1. FDA approves first-of-its-kind drug to treat hot flashes  GMA
  2. F.D.A. Approves New Drug to Treat Hot Flashes  The New York Times
  3. FDA green lights a new type of drug for menopausal hot flashes  CNN
  4. New hot flashes treatment: FDA approves drug for night sweats  NBC News
  5. New menopause drug for hot flashes gets FDA approval  AOL

Want the full story? Read the original reporting

Read on GMA